London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
As far as I know, Mr Ford has been unable to return to his family in Oz for a long time, due to restrictions.
Particularly insensitive to him at this particular period IMHO
Hi gixer,
Fully agreed. We should have COVID patent. It seems this COVID is going to stay for long period of time. Look what has happened to SAR, who just completed a POC study for COVID and they are now sky rocketing. Hope IF is keeping an eye on all these not just comfortably taking his salary and enjoying Australian sun and wine.
alfista, "Surely the patent is on the method of production."
Yip that's the one we need to keep a hold of but (as far as I am aware) it doesn't stop other people / companies applying for patents with Fruitflow for other benefits it may have and is not already patented. Remember Asim and Oslo Uni patented fruitflow as an antihypertensive agent that we now own.
slightly different but By-Health have a patent for a "COMPOSITION FACILITATING LOWERING OF BLOOD PRESSURE AND DIETARY SUPPLEMENT" that contains Fruitflow.
https://patentscope.wipo.int/search/en/detail.jsf?docId=WO2020077747&_cid=P11-KRPWOM-31834-1
As long as we own the patent for the method of production then we can control the sale of the product but I do hope we have a FF/Covid patent in the pipeline.
Hi gixer,
Great find. So it seems CV is at the fore front of govt's health initiative. Hope PXS could use this in their favour and sign few contracts.
Surely the patent is on the method of production.
Fruitflow Plus Facebook and Twitter page so yes it would have been Provexis although I am unsure who is doing the social media for us atm.
Hi Gixer - It's Sock here. The Facebook link in your last message, who would have posted it? Is it Provexis who would have written it? Thanks
I am by no way saying there is a connection but....
https://www.bhf.org.uk/what-we-do/news-from-the-bhf/news-archive/2021/july/life-sciences-vision-to-deliver-innovation-to-people-with-heart-and-circulatory-disease
https://twitter.com/FruitflowPlus/status/1418458366498770945
https://www.facebook.com/fruitflowplus/posts/2629085147392474
Just for the sake of conjecture, I wonder what the legal position would be if BY-Health decided to do the studies and trials in China. I am presuming here that Provexis already own the IP/patents on the various "supplements" properties of FF. However, if BY-Health crossed the IP over into "mainstream medicines", would the IP transfer to them.
It's this weird site ws, sometimes you just can't find recent posts - most confusing! Wish they would sort it out.
I'm not sure the fast-tracking of vaccines in a pandemic is going to help us get over the many, many hurdles that would lie between FF and a pharma application. There is a government-backed route to funding (AGILE), but since neither PXS or DSM has applied for funding to progress a claim I guess they don't think it would fly.
The main issue for me is the huge cost of any trials required to upgrade from food supplement to medication claims. I can't see DSM stumping up for it as it's not their area, so where would the money come from? Even a P1 trial would involve commitment of several £m and that's just the start.
Supplements have been prescribed by GP's for years. I worked in GP land in the 90's & we were doing it then (mostly GF breads etc.).
Completely agree with you re the potential here, clearly not reflected in the current SP. It won't move, though, without significant increases in sales volume and/or news from BYHEALTH, both of which are eagerly awaited. K
Dunno what happened there, waited an hour to see if first draft would eventually appear .......
Krusty
Not so massive imho. The world has moved on, look how quickly the vaccines were developed and approved, if there is a need for it, things can be fast tracked
Going back to the Prof’s presentation, from 1:31 onwards it does suggest we are going the medical route. We shall know by the AGM how far along FF has been progressed (if at all). As is the case the issue has been how to get FF to those who need it the most. For example, at £15 a pop I don’t see those who could benefit the most from its impact on the effects of air pollution would ever take it.
https://airqualitynews.com/2019/06/19/poor-most-exposed-to-air-pollution-caused-by-rich-study-finds/
Supplements can be prescribed by GPs etc. they just need the justification to do so……
Regardless of what happens in the near term, the potential is there and should be captured in the IP value.
Looking forward to the next update, we are getting closer to boom or bust time.
W-WTFDIK-S
Krusty
- massive jump, not so sure.
Viewing the prof's presentation again, particularly after 1:31, it does strongly suggest we are going the medical route. Whether already started or the prof's paper shall be the justification to start, we'll know by the AGM. To be any use for CV the studies etc. would have to be fast -tracked, in a similar fashion the vaccines were.
However, like all things FF, the issue has always been getting it to the people who would most benefit as, take pollution for example, I do not see FF at £15 a shot will ever help those would benefit the most from it.
https://airqualitynews.com/2019/06/19/poor-most-exposed-to-air-pollution-caused-by-rich-study-finds/
Supplements etc. can be prescribed now by GPs etc. From personal experience GP's are very aware of FF, never heard of it being prescribed though.
Like all of us, not holding my breath, but as future potential is does add value to the IP
W?
I can't see it rpg7, as interesting as it could be. It's a massive jump from dietary supplements to medical application. Having said that, if any of the Chinese research comes to fruition, it's much more likely one of the big pharma players would be interested in partnering with PXS/DSM to take something forward.
Posted the article to indicate the market potential, Fruitflow being an over the counter supplement would not qualify. Roll on clinical trials ----or maybe not.
Tells you everything you need to know, right at the top of the document:
"Industry
Pharmaceutical products - 33600000
Various medicinal products - 33690000"
Absolutely agree alf, no way can our dietary supplement meet the criteria for supplying the NHS with anticoags, however good we might think it is. This is strictly warfarin territory IMHO.
Wouldn't get too excited about that one, absolutely no chance of any bid to supply a non drug dietary supplement for that use IMHO
Rpg7
Where did you see that published?
rpg,
So could PXS/DSM bid for supplying Fruitflow?
NHS Framework Agreement for the supply of Direct Oral Anticoagulants (DOACs) for the NHS in England.
Open opportunity -This means that the contract is currently active, and the buying department is looking for potential suppliers to fulfil the contract.
Value of contract £3,185,000,000
Published date 22nd July 2021
Closing date 3rd September 2021
"Fruitflow Proven to Prevent Platelet Aggression, Can Be Used to Reduce Covid-19 Death Risk"
https://www.wartaekonomi.co.id/read352526/fruitflow-terbukti-cegah-agresi-trombosit-bisa-dimanfaatkan-untuk-tekan-risiko-kematian-covid-19